UBS Group’s Aehr Test Systems AEHR Stock Holding History
Bought
Maintained
Sold
Other funds holding AEHR
UBS Group's AEHR Position: Q3 2026 in Review
UBS Group increased its Aehr Test Systems (AEHR) stake by 20% in Q3 2026, buying an estimated $3.18M and bringing the position to 203,788 shares worth $20.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.
UBS Group first reported a position in AEHR in Q4 2014 and has held it in 32 quarters since. 298 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.
- UBS Group held 203,788 shares of Aehr Test Systems worth $20.3M as of Q3 2026.
- UBS Group bought 34,665 Aehr Test Systems shares in Q3 2026, an estimated $3.18M.
- Aehr Test Systems made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2648 holding.
- UBS Group first reported a position in Aehr Test Systems in Q4 2014 and has held it in 32 quarters since.
- 298 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.